2016 Coverage, Reimbursement & Health Policy Conference Agenda

MDMA's 19th Annual Coverage, Reimbursement

& Health Policy Conference


*Speakers will be added as confirmed

Click Here for a PDF of the Agenda

Wednesday, November 16, 2016

3:30pm - 5:30pm - Reimbursement and the Product Development Cycle: Inception through Commercialization

"Reimbursement" is a concept that reflects the strategy and implementation activities that result in market access as to how the product and associated services may be covered by health insurance, may be described by codes, and may be paid. Now that providers and patients in addition to payers, have financial risk, reimbursement activities must take into account the economic and financial implications for all parties. Importantly, actions related to reimbursement are different based on where the product is in its stage of development. This session will illustrate how the reimbursement tactics, strategy and implementation road-map align with the product development cycle and the business strategy.

  • Judy Rosenbloom, Founder & President, JR Associates
  • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates

5:00pm - 7:00pm - Networking Reception

Thursday, November 17, 2016

7:30am - 8:55am - Networking & Continental Breakfast

8:55am - 9:00am - Welcoming Remarks

  • Mark Leahey, President & CEO, MDMA

9:00am - 9:45am -CMS and the New World of Value

Earlier this year, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule implementing provisions from the Medicare Access and CHIP Reauthorization Act (MACRA) that change the way Medicare pays physicians, moving to value-based and alternative payment models. The agency is also engaged in complementary efforts with several pilots that tie reimbursement to the value of health care provided to Medicare beneficiaries. As CMS continues to develop new reimbursement models and incentives for innovators, hear from the agency on how you and your teams can prepare for this new environment, and what other reforms CMS is working on.

    9:45am - 10:30am -Quality Over Quantity: The New Normal in Health Care

    Over the last few years, the healthcare reimbursement landscape has begun to shift towards a greater emphasis on quality and value after decades of fee-for-service payments. Both Medicare and commercial payers are piloting and/or implementing efforts to reduce costs and improve care coordination and quality of healthcare delivery. Learn about the current and changing reimbursement landscape, including changes in evidentiary requirements in quality and performance measurement, what it could mean for you, and if there is a future for fee-for-service in the shifting landscape.

    • Curtis Medeiros, President, OPTUM Life Sciences

    10:30am - 10:45am - Networking Break

    10:45am - 11:30am - Demonstrating Value to Private Payers and Providers

    In today's environment medical technology companies must demonstrate the value and patient benefit of their product to providers and payers. Leading experts will share what payers and providers are looking for today from medical technologies and will review steps companies can take to help ensure their technologies get into the hands of patients and providers.

    11:30am - 12:15pm - Securing Coverage with CMS

    We expect Medicare fee-for-service coverage policy and its evidence reviews will continue to be a benchmark even as Medicare moves to alternative value based payment systems. Hear from a leading CMS policy maker what the agency is doing to support the development of evidence for new devices. Learn strategies for meeting with local Medicare Administrative Contractors (MACs), how to demonstrate value of the device, and what mistakes to avoid while working with local MACs.

    • Laurence Clark, MD, FACP, National Government Services
    • Louis Jacques, Senior Vice President & Chief Clinical Officer, ADVI
    • Murray Sheldon, MD, Associate Director for Technology & Innovation, CDRH, FDA

    12:15pm - 1:15pm - Buffet Luncheon & Election Update

    MDMA’s President & CEO will provide an update on Congressional and election activities, and what to expect with a new administration and Congress in place for 2017 and beyond.

    • Mark Leahey, President & CEO, MDMA

    1:15pm - 2:00pm - Navigating CPT and RUC

    The CPT and RUC processes can be confusing and challenging. A former AMA CPT Director will help you understand what evidence you need to secure a CPT code and maximize your product's reimbursement, while a current AMA staff member will provide a background of the RUC and how the RUC provides value recommendations to CMS.

    • Michael Beebe, Senior Vice President, ADVI
    • Dawn Gray, Director of Reimbursement and Regulatory Affairs, Socient for Cardia Angiography and Interventions (SCAI)

    2:00pm - 2:45pm - On the Horizon: Reimbursement and Telehealth

    Medical device companies are increasing the integration of cloud based data and mobile applications, resulting in various telehealth capabilities. These features influence health care by connecting the patient to the provider remotely, and storing quantitative data for physician review. These products introduce reimbursement complexity related to where they fit within health plan benefits, how the product or application and related provider services can be described in coding nomenclature, and how these features and services will be paid. This session will introduce key questions providers and payers are asking and what factors manufacturers have to address to gain adoption.

    • Judy Rosenbloom, Founder & President, JR Associates
    • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates

    2:45pm - 3:00pm - Networking Break

    3:00pm - 4:00pm - International Opportunities, Familiar Challenges

    International Reimbursement issues continue to change and present problems for medical device manufacturers. Learn about the status of China's procedure code and procurement policies, new changes in the German innovation payment, and the UK's web based formularies for devices and more.

    • Stephen Hull, Founder & President, Hull Associates
    • Ed Rozynski, Senior International Advisor, MDMA


    Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.